PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Discovery of mechanisms predicting response to new treatments in colon cancer

2012-05-21
(Press-News.org) Barcelona, 20 May 2012. The Stem Cells and Cancer Research Group headed by Dr Héctor G. Palmer at the Vall d'Hebrón Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Muñoz´s laboratory at the Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Científicas (IIB-CSIC-Madrid). Published today in Nature Medicine, this work identifies biomarkers that predict response to treatment and proposes therapeutic solutions for patients who do not respond well. These advances will guide better selection of treatments and avoid the risk of administering ineffective drugs.

Colon cancer is a disease caused by a malignant tumour in the large intestine. When detected early the tumor is removed through surgery and patients are treated with adjuvant chemotherapy, eliminating the disease in the majority of cases. However, in advanced stages, colon tumours are resistant to a broad spectrum of anti-tumour drugs and cancerous cells escape treatment and disseminate around the body, giving rise to metastasis. Currently there are no effective treatments to halt the progression of colon cancer in these later stages and most patients die as a result of disease progression.

Over recent years new drugs have been designed to target and block the activity of certain molecules responsible for promoting tumor growth and metastasis. Some of these, which are currently in clinical trials, are showing promising results in certain patients, while others show no improvement at all. This study headed by the VHIO examines the differential response to treatment and was supported by the Olga Torres Foundation (FOT), the Scientific Foundation of the Spanish Association Against Cancer (AECC), and the Carlos III Institute of Health (ISCIII).

New clinical horizons

Dr Héctor G. Palmer´s team has described for the first time the molecular mechanisms through which the interaction between the oncogenic pathways of Wnt/beta-catenin and RAS/PI3K/AKT determines the response to treatments with pharmacological PI3K or AKT inhibitors. Although both pathways are genetically altered in colon cancer, it is the over-accumulation of beta-catenin in the nucleus of cancer cells that makes them resistant to cell death induced by these anti-tumoral drugs.

Activation of the PI3K/AKT pathway retains the FOXO3a protein outside the cell nucleus, inhibiting its ability to act as a tumour suppressor that induces cell death. Therefore, "Targeting PI3K or AKT activity with these novel inhibitors allows relocation of FOXO3a in the nucleus promoting cell death. These drugs are being tested in clinical trials worldwide providing promising initial results in certain tumour types", explains Héctor G. Palmer, Head of VHIO´s Stem Cells and Cancer Group.

However, many colon cancer patients do not show any benefit. The reason for this is explained by Dr Palmer: "If the patients treated with these inhibitors show very high levels of nuclear beta-catenin, FOXO3a cannot induce cell death but promotes the opposite effect by escaping treatment and causing metastasis." According to Héctor Palmer, this finding has tremendous clinical value, since "the identification of nuclear beta-catenin as a biomarker to predict response guides the selection of patients who will benefit from treatment with PI3K or AKT inhibitors and discard their use in candidates who would provoke an adverse response."

Furthermore, Dr Héctor Palmer and his collaborators have discovered a solution for those patients for whom treatment with PI3K or AKT inhibitors would be contraindicated. They used an experimental drug that reduces the levels of nuclear beta-catenin, allowing the cell death induced PI3K or AKT inhibitors. These findings propose the combination of both types of inhibitors in the future for a more effective target-directed therapy in colon cancer.

Delivering on the promise of personalized medicine

VHIO pioneers pre-clinical functional studies and clinical trials in the fight against cancer. Importantly, Dr. Palmer´s team has developed in vivo models that accurately recapitulate disease progression in colon cancer patients. They inoculate the animals with cells derived from the patient's tumour, creating a "xenopatient" model. These cells regenerate the the disease in the animals with the same distinctive characteristics as in the individual patient, retaining its original genetic, clinical and pathological alterations. The xenopatients represent a parallel reality of each patient in the laboratory. This approach allows the study of disease progression and response to experimental medicines before subjecting the patient to new treatments. This model could soon form the basis of future functional, predictive and personalized cancer treatments.

INFORMATION:

For further information:
Amanda Wren
Communication Manager
Vall d'Hebron Institute of Oncology (VHIO)
Tel. +34 695 207886
e-mail: awren@vhio.net

END



ELSE PRESS RELEASES FROM THIS DATE:

Blocking DNA: HDAC inhibitor targets triple negative breast cancer

2012-05-21
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research. Researchers from Tulane University Health Sciences Center have shown that panobinostat was able to destroy breast cancer cells and reduce tumor growth in mice. Approximately 15% of breast cancers are found at diagnosis to be triple negative. These aggressive tumours are missing both the estrogen receptor and progesterone receptor, which means that they do not respond ...

ApparelUS.com, Wholesale Apparel Retailer, is Now Offering Discounts of Up to 60 Percent on All Clothing

ApparelUS.com, Wholesale Apparel Retailer, is Now Offering Discounts of Up to 60 Percent on All Clothing
2012-05-21
Finding the right clothes at the right price can be an inconvenient chore for those that do not know where to look. It will not take much to be forced to overpay, especially when on the search for wholesale apparel that is stylish and fashion forward. With some of the huge discounts of up to 60 percent now offered by the leading wholesale clothing retailer, ApparelUS.com, customers are now finding the outfits that they need while staying within their budget. Purchasing wholesale clothes in person can turn into a lengthy ordeal with pushy salespeople and second-rate items. ...

Soldiers who desecrate the dead see themselves as hunters

2012-05-21
Modern day soldiers who mutilate enemy corpses or take body-parts as trophies are usually thought to be suffering from the extreme stresses of battle. But, research funded by the Economic and Social Research Council (ESRC) shows that this sort of misconduct has most often been carried out by fighters who viewed the enemy as racially different from themselves and used images of the hunt to describe their actions. "The roots of this behaviour lie not in individual psychological disorders," says Professor Simon Harrison who carried out the study, "but in a social history ...

Scientists discover distinct molecular subtype of prostate cancer

2012-05-21
NEW YORK, CAMBRIDGE, Mass., AND BOSTON (May 20, 2012) -- A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical College, the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute. In the study, published online May 20 by the journal Nature Genetics, investigators describe how they discovered novel mutations in the SPOP ("S-pop") gene in numerous patient tumors, saying this alteration is ...

Wilshire Dental Care is Now Offering Free In-Office Teeth Whitening

Wilshire Dental Care is Now Offering Free In-Office Teeth Whitening
2012-05-21
The teeth whitening industry has become very popular in recent years as individuals are now looking for the most effective and pain-free treatments that will create a bright and lustrous smile. Finding a dental practice that is going to put a patient at ease and provide affordable and effective services at the same time can be difficult though, but the choice is now just a little bit easier for residents of Los Angeles. Dr. Afar, Los Angeles dentist, is now offering free in-office teeth whitening to all new patients that would like a vibrant smile this summer. Visit WilshireDentalCare.com ...

Impact of MRSA nasal colonization on surgical site infections after gastrointestinal surgery

2012-05-21
Methicillin-resistant Staphylococcus (MRSA) nasal colonization is associated with longer hospital stays and an increase in surgical site infections (SSI) in patients undergoing major gastrointestinal surgery, according to a new study from Scott and White Memorial Hospital, Temple, TX. Antibiotic-resistant organisms such as MRSA can cause infections after surgery. Many studies have shown that MRSA nasal colonization increases the risk of developing SSI, and there has been an effort to conduct swab testing to isolate those patients and decontaminate or reduce the risk ...

Relief of urinary symptoms is an underappreciated benefit of early stage prostate cancer treatment

2012-05-21
BOSTON – Treatment of early stage prostate cancer can also result in improved quality of life for a subgroup of men who suffer from lower urinary tract symptoms (LUTS), according to an abstract of a Beth Israel Deaconess Medical Center-led study presented to the American Urological Association. LUTS, which includes problems of frequent or urgent urination, particularly at night, is a common problem that affects approximately 40 percent of men, a percentage that rises with age. It is not a reason to suspect prostate cancer. "Possible benefits of prostate cancer treatment ...

Experimental bariatric surgery controls blood sugar in rats with diabetes

Experimental bariatric surgery controls blood sugar in rats with diabetes
2012-05-21
For the first time, scientists at the Toronto General Hospital Research Institute have shown that an experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes. A team led by Dr. Tony Lam and Dr. Danna Breen, a post- doctoral fellow in the lab of Dr. Lam, used a rat model to study novel nutrient-sensing signals in the jejunum, located in the middle of the intestine. Dr. Lam and his team demonstrate that duodenal-jejunal bypass surgery activates novel nutrient-sensing signals in the jejunum and rapidly lowers blood sugar levels in non-obese ...

NOHO Dental Group is Now Offering Special Discounts on Invisalign Aligners

NOHO Dental Group is Now Offering Special Discounts on Invisalign Aligners
2012-05-21
Many of those with misaligned teeth or gaps in their smile may be hesitant about seeking out treatment due to the fact that they would like to steer clear from traditional metal braces. Even though these appliances work wonderfully for those that would like a straight and balanced smile, they do come with a handful of drawbacks. For those that are looking for an affordable alternative, Dr. Afar, North Hollywood dentist, is now offering huge discounts on Invisalign aligners, one of the most advanced teeth straightening systems in the world. Visit BestNorthHollywoodDentist.com ...

New Jersey Law Firm Hanan M. Isaacs, P.C. Welcomes Misty Velasques

2012-05-21
Hanan M. Isaacs, P.C. with offices located in Kingston, New Jersey, is proud to announce their hiring of the newest attorney member of the firm, Misty Velasques. Ms. Velasques will focus on family law and employment law, while supporting other areas of general civil practice. Ms. Velasques graduated from Thomas M. Cooley Law School in 2011. She worked for a general practice law firm while attending law school in Lansing, Michigan. Additionally, she participated in the law school's Mock Trial Board and the Disaster Relief Legal Association. Recently, Ms. Velasques sat ...

LAST 30 PRESS RELEASES:

Pavlov’s dogs were conditioned to go to their treat. Why do some animals learn to interact with the bell instead?

Call for Young Editorial Board members at Current Molecular Pharmacology

MSU team develops scalable climate solutions for agricultural carbon markets

Playing an instrument may protect against cognitive aging

UNM study finds link between Grand Canyon landslide and Meteor Crater impact

Ultra-hot Jupiter’s death spiral could reveal stellar secrets

You only get one brain! The best helmet material for protecting your noggin

Neurodegeneration and stroke after GLP-1RAs in diabetes and obesity

Pediatric COVID-19 hospitalization trends by race and ethnicity, 2020-2023

Research spotlight: New genetic roadmap offers insights into obesity and diabetes

Fred Hutch leads new Vanguard Study for Cancer Screening Research Network

‘Mismatched’ transplants now safe, effective for blood cancer patients, study finds

New research helps narrow down uncertainties in near-term precipitation projections for the Asian Water Tower

AI tool accurately detects tumor location on breast MRI

Researchers use OCT imaging to uncover how the fallopian tube transports embryos

PolyU secures RGC theme-based research scheme funding to develop cost-effective and sustainable Co-GenAI model

Van Andel Institute scientists develop technique for high-resolution single cell epigenetic analysis

The Lundquist Institute wins multi-year NIH grant exceeding $11 million to transform diagnosis and treatment of deadly mucormycosis

Review suggests ending adult boosters for tetanus, diphtheria

ESMT Berlin welcomes Rebecca Schaumberg to faculty

Blocking a little-known protein may offer new hope for devastating lung disease

Medieval medicine was smarter than you think – and weirdly similar to TikTok trends

FAU receives NIH grant to investigate amphetamine addiction

Realizing on-site carbon nanotube photo-thermoelectric imaging

Most of us love memes. But are they a form of comics?

Novel biosensor allows real-time monitoring of sucrose uptake in plants

Korea University researchers reveal revealing how WEE1 drives cancer resistance to immunotherapy

Pusan National University researchers develop breakthrough deep learning model that enhances handheld 3D medical imaging

SLAS Discovery and SLAS Technology demonstrate research impact with 2024 impact factors

Disease-causing bacteria can deal with stink as long as they get a meal

[Press-News.org] Discovery of mechanisms predicting response to new treatments in colon cancer